Amicus Therapeutics Inc (FOLD)
7.50
-0.50
(-6.25%)
USD |
NASDAQ |
Apr 04, 16:00
7.49
-0.01
(-0.13%)
After-Hours: 20:00
Amicus Therapeutics Shareholders Equity (Quarterly): 194.04M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.658B |
| Insmed Inc | 285.38M |
| Vanda Pharmaceuticals Inc | 538.55M |
| Vertex Pharmaceuticals Inc | 16.41B |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 785.03M |
| Total Liabilities (Quarterly) | 590.99M |
| Debt to Equity Ratio | 2.010 |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | 0.03% |